WASHINGTON, Nov 13 (Reuters) - Roche AG’s influenza drug Tamiflu will come with a new caution urging close monitoring of patients for abnormal behavior such as delirium and self-injury, U.S. regulators said on Monday.
WASHINGTON, Nov 13 (Reuters) - Roche AG’s influenza drug Tamiflu will come with a new caution urging close monitoring of patients for abnormal behavior such as delirium and self-injury, U.S. regulators said on Monday.
